Shari Marchbein is a Dermatology physician affiliated with New York University. OpenAlex indexes 8 publications with 256 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
370 Lexington Ave Rm 1003
New York, NY 100176586
Telephone
212-789-0890Provider last certified this registry record 16 May 2022.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- REVANCE THERAPEUTICS, INC.Program year20252 payments$27,150openpaymentsdata.cms.gov ↗
- REVANCE THERAPEUTICS, INC.Program year20241 payment
- ABBVIE INC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
49%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor27.5%Valacyclovir100%Part D<11 patientsAzole Antifungal21.6%Ketoconazole100%Part D<11 patientsSensory organs
27.5%Corticosteroid27.5%Clobetasol Propionate100%Part D<11 patientsMetabolism & gastrointestinal
23.5%Vitamins, other combinations23.5%Azelaic Acid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- <i>Macrocystis pyrifera</i> ferment‐containing creams for optimizing facial skin rejuvenation
Journal of Cosmetic Dermatology
2023 - Evidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare Products into Treatment Regimens
Journal of Drugs in Dermatology
2021 - Iconography : Androgens in women : Androgen-mediated skin disease and patient evaluation2019
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Galetta, MD
New York University
Herbert Lepor, MD
New York University
Aasma Shaukat, MD
New York University
Jerry Shapiro, MD
New York University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”